Paola Queirolo

ScholarGPS® ID: 89888758491724

Affiliation

Istituto di Ricovero e Cura a Carattere Scientifico, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

291

Predicted Citations

13,669

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma (journal article) De Simoni, Edoardo \| Spagnolo, Francesco \| Gandini, Sara \| Gaeta, Aurora \| Rizzetto, Giulio \| Molinelli, Elisa \| Simonetti, Oriana \| Offidani, Annamaria \| Queirolo, Paola Cancer Treatment Reviews, volume 129 (2024). 10.1016/j.ctrv.2024.102788 Cite \| Source
Association between PD-1 single nucleotide gene variants and the risk of metastatic melanoma (journal article) Boutros, Andrea \| Carosio, Roberta \| Campanella, Dalila \| Banelli, Barbara \| Morabito, Anna \| Pistillo, Maria Pia \| Croce, Elena \| Queirolo, Paola \| Tanda, Enrica Teresa \| Raposio, Edoardo \| ... \| Spagnolo, Francesco Archives of Dermatological Research, volume 316, issue 7 (2024). 10.1007/s00403-024-03034-9 Cite \| Source
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (journal article) Queirolo, P. \| Cinquini, M. \| Argenziano, G. \| Bassetto, F. \| Bossi, P. \| Boutros, A. \| Clemente, C. \| de Giorgi, V. \| Del Vecchio, M. \| Patuzzo, R. \| ... \| Spagnolo, F. ESMO Open, volume 9, issue 5, pages 103005- (2024). 10.1016/j.esmoop.2024.103005 Cite \| Source
Melanoma Brain Metastases: Immunotherapy or Targeted Therapy? A Systematic Review and Meta-Analyses (journal article) Onofrio, Livia \| Gaeta, Aurora \| D’Ecclesiis, Oriana \| Cugliari, Giovanni \| Gandini, Sara \| Queirolo, Paola Applied Sciences, volume 14, issue 6, pages 2222- (2024). 10.3390/app14062222 Cite \| Source
Electronic patient-reported outcomes, fever management, and symptom prediction among patients with BRAF V600 mutant stage III–IV melanoma: The Kaiku Health platform (journal article) Mohr, Peter \| Ascierto, Paolo \| Addeo, Alfredo \| Vitale, Maria Grazia \| Queirolo, Paola \| Blank, Christian \| Ekström, Jussi \| Vainio, Joonas \| Kataja, Vesa \| Gunes, Sibel \| ... \| Lijnsvelt, Judith EJC Skin Cancer, volume 2 (2024). 10.1016/j.ejcskn.2024.100254 Cite \| Source
The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis (journal article) Tosti, Giulio \| Pepe, Francesca \| Gnagnarella, Patrizia \| Silvestri, Flavia \| Gaeta, Aurora \| Queirolo, Paola \| Gandini, Sara Nutrients, volume 16, issue 1, pages 100- (2023). 10.3390/nu16010100 Cited by (1) \| Cite \| Source
The predictive and prognostic role of single nucleotide gene variants of PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors (journal article) Boutros, A. \| Carosio, R. \| Campanella, D. \| Spagnolo, F. \| Banelli, B. \| Morabito, A. \| Pistillo, M.P. \| Croce, E. \| Cecchi, F. \| Pronzato, P. \| ... \| Tanda, E.T. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100408 Cited by (1) \| Cite \| Source
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study (journal article) Dummer, Reinhard \| Queirolo, Paola \| Gerard Duhard, Pauline \| Hu, Youyou \| Wang, Dao \| de Azevedo, Sergio Jobim \| Robert, Caroline \| Ascierto, Paolo Antonio \| Chiarion-Sileni, Vanna \| Pronzato, Paolo \| ... \| Tawbi, Hussein The Lancet Oncology, volume 24, issue 12, pages e461-e471 (2023). 10.1016/S1470-2045(23)00334-0 Cited by (17) \| Cite \| Source
782-H Effects of an AI generated personalized neopeptide-based immunotherapy, EVX-01, in combination with pembrolizumab in patients with metastatic melanoma: a clinical trial update (conference) Khattak, Adnan \| Ascierto, Paolo A \| Queirolo, Paola \| Chisamore, Michael \| Kleine-Kohlbrecher, Daniela \| Viborg, Nadia \| Lausen, Mads \| Thorsen, Stine F \| Trolle, Thomas \| Jespersen, Anders \| Long, Georgina V SITC 38th Annual Meeting (SITC 2023) Abstracts Supplement 2 (2023) 10.1136/jitc-2023-SITC2023.0782-H Cite \| Source
Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors (journal article) Bossi, Paolo \| Ascierto, Paolo A. \| Basset-Seguin, Nicole \| Dreno, Brigitte \| Dummer, Reinhard \| Hauschild, Axel \| Mohr, Peter \| Kaufmann, Roland \| Pellacani, Giovanni \| Puig, Susana \| ... \| Peris, Ketty Critical Reviews in Oncology/Hematology, volume 189 (2023). 10.1016/j.critrevonc.2023.104066 Cited by (8) \| Cite \| Source
NEO-CESQ study: Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma. (journal article) Ascierto, Paolo Antonio \| Bossi, Paolo \| Mandalà, Mario \| Queirolo, Paola \| Spagnolo, Francesco \| Bassetto, Franco \| Rampinelli, Vittorio \| Giovacchini, Francesco \| Pennacchioli, Elisabetta \| Caraco, Corrado \| ... \| Chiarion-Sileni, Vanna Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 9576-9576 (2023). 10.1200/JCO.2023.41.16_suppl.9576 Cited by (2) \| Cite \| Source
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study (journal article) Del Vecchio, Michele \| Chiarion Sileni, Vanna \| Quaglino, Pietro \| Rinaldi, Gaetana \| Minisini, Alessandro \| Troiani, Teresa \| Consoli, Francesca \| Sponghini, Andrea \| Banzi, Maria \| Morelli, Maria Francesca \| ... \| Queirolo, Paola Cancers, volume 15, issue 7, pages 1980- (2023). 10.3390/cancers15071980 Cite \| Source
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study (journal article) Ascierto, Paolo A. \| Cioli, Eleonora \| Chiarion-Sileni, Vanna \| Quaglino, Pietro \| Spagnolo, Francesco \| Guidoboni, Massimo \| Del Vecchio, Michele \| Peris, Ketty \| Queirolo, Paola \| Fioretto, Luisa \| ... \| Trojaniello, Claudia Frontiers in Oncology, volume 13 (2023). 10.3389/fonc.2023.1107307 Cited by (1) \| Cite \| Source
Characteristics of Real-World Patients with High-Risk BRAFV600E/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program (journal article) Quaglino, Pietro \| Ascierto, Paolo A \| Consoli, Francesca \| Queirolo, Paola \| Spagnolo, Francesco \| Morelli, Maria \| Berardi, Rossana \| Chiarion-Sileni, Vanna \| Tucci, Marco \| Troiani, Teresa \| ... \| Del Vecchio, Michele Cancer Management and Research, volume Volume 15 (2023). 10.2147/CMAR.S423970 Cite \| Source
Genetic Alterations of Melanoma Brain Metastases: A Systematic Review and Meta-Analysis (journal article) Pala, Laura \| Bagnardi, Vincenzo \| Tettamanzi, Francesca \| Barberis, Massimo \| Mazzarol, Giovanni \| Casali, Cecilia \| De Pas, Tommaso \| Pennacchioli, Elisabetta \| Coppola, Sara \| Baldini, Federica \| ... \| Conforti, Fabio Molecular Diagnosis & Therapy, volume 27, issue 1, pages 5-13 (2023). 10.1007/s40291-022-00623-0 Cite \| Source
24P The predictive and prognostic role of single nucleotide gene variants in PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors (journal article) Boutros, A. \| Carosio, R. \| Campanella, D. \| Spagnolo, F. \| Banelli, B. \| Morabito, A. \| Pistillo, M.P. \| Croce, E. \| Cecchi, F. \| Pronzato, P. \| ... \| Tanda, E.T. Immuno-Oncology and Technology, volume 16 (2022). 10.1016/j.iotech.2022.100129 Cited by (1) \| Cite \| Source
813P Time to development of central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined with vemurafenib (V) + cobimetinib (C): Updated results from the phase III IMspire150 study (journal article) Lewis, K. \| Robert, C. \| Ramella Munhoz, R. \| Liszkay, G. \| de la Cruz Merino, L. \| Olah, J. \| Queirolo, P. \| Mackiewicz, J. \| Li, H. \| Zhu, Q. \| ... \| Ascierto, P.A. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.939 Cited by (1) \| Cite \| Source
RETRACTED: Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study (journal article) Dummer, Reinhard \| Queirolo, Paola \| Abajo Guijarro, Ana Maria \| Hu, Youyou \| Wang, Dao \| de Azevedo, Sergio Jobim \| Robert, Caroline \| Ascierto, Paolo Antonio \| Chiarion-Sileni, Vanna \| Pronzato, Paolo \| ... \| Tawbi, Hussein The Lancet Oncology, volume 23, issue 9, pages 1145-1155 (2022). 10.1016/S1470-2045(22)00452-1 Cited by (34) \| Cite \| Source
833P Longer follow up of a real-world study of cemiplimab in advanced cutaneous squamous cell carcinoma: Focus on late toxicities and long term benefit (journal article) Quaglino, P. \| Baggi, A. \| Depenni, R. \| Guida, M. \| Ascierto, P.A. \| Queirolo, P. \| Peris, K. \| Spagnolo, F. \| Bianchi, L. \| De Galitiis, F. \| ... \| Bossi, P. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.959 Cite \| Source
840P Electronic patient-reported outcomes (ePROs) of adults with BRAF V600–mutant stage III-IV melanoma treated with dabrafenib + trametinib (D + T) collected using the Kaiku Health digital patient (pt) monitoring platform (journal article) Lijnsvelt, J. \| Addeo, A. \| Vitale, M.G. \| Mohr, P. \| Queirolo, P. \| Ekström, J. \| Vainio, J. \| Kataja, V.V. \| Calado, F. \| Fagan, A. \| ... \| Ascierto, P.A. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.966 Cited by (1) \| Cite \| Source